KRAS and neoplasm: In a multivariable analysis including sex, ancestry, smoking, EGFR mutations, KRAS mutations, and mutational signature ID2 in relation to tumor latency (Fig. 2e), ID2 had the strongest effect size, followed by EGFR mutations and sex, suggesting an independent impact of these factors on LUAD evolution.